Genenta Science S.p.A. (GNTA)
NASDAQ: GNTA · Real-Time Price · USD
3.220
-0.080 (-2.42%)
Oct 6, 2025, 4:00 PM EDT - Market closed
Genenta Science Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for Genenta Science.
Price Target: $ (0.00%)
Analyst Consensus: n/a
Analyst Ratings
There are currently no analyst ratings available for Genenta Science.
Recommendation Trends
Rating | May '24 | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 |
---|---|---|---|---|---|---|
Strong Buy | 2 | 2 | 2 | 2 | 2 | 0 |
Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 2 | 2 | 2 | 2 | 2 | 0 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $25 | Strong Buy | Reiterates | $25 | +676.40% | Oct 2, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $25 | Strong Buy | Reiterates | $25 | +676.40% | May 13, 2024 |
Roth MKM | Roth MKM | Strong Buy Initiates $15 | Strong Buy | Initiates | $15 | +365.84% | Jun 29, 2023 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $25 | Strong Buy | Reiterates | $25 | +676.40% | Feb 8, 2023 |
EF Hutton | EF Hutton | Strong Buy Initiates $15 | Strong Buy | Initiates | $15 | +365.84% | Jan 5, 2023 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-0.72
from -0.49
EPS Next Year
-0.71
from -0.72
Financial currency is EUR. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 |
---|---|
High | n/a |
Avg | n/a |
Low | n/a |
Revenue Growth
Revenue Growth | 2025 |
---|---|
High | - |
Avg | - |
Low | - |
EPS Forecast
EPS | 2025 | 2026 |
---|---|---|
High | -0.75 | -0.74 |
Avg | -0.72 | -0.71 |
Low | -0.70 | -0.69 |
EPS Growth
EPS Growth | 2025 | 2026 |
---|---|---|
High | - | - |
Avg | - | - |
Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.